Improvement in staging of prostate cancer

Three-dimensional transrectal ultrasonography (3D-TRUS) allows accurate 3D examination of pathological structures and prediction of extracapsular tumor extension.

Medisons Accuvix XQ Prestige 07 - a real-time 3D US scanner.
Medison's Accuvix XQ Prestige 07 - a real-time 3D US scanner.
180 randomly selected patiens with initial diagnosed prostate cancer participated in a study at the Medical University of Innsbruck. Dr. Michael Mitterberger and colleagues used 3D-TRUS, which provides ultrasonograms in three planes simultaneously, for local staging of prostate cancer.

“3D-TRUS can be used with no problems and is a simple procedure allowing exact assessement for staging prostate cancer,” said Dr, Mitterberger. “Locally confined and locally advanced prostate cancer can be differentiated with maximum convenience, reliability, and ease.”
3D-TRUS highly increase chances to detect pathological capsular perforation of the tumor: It predicted 44 of 53 cases correctly and features an overall accuracy of 96%.

The investigators conclude their report in the July issue of BJU International: “3D-Trus can be considered to guide the decision before a planned radical prostatectomy. If 3D-TRUS indicated locally advanced disease, the probability of capsular perforation or seminal vesicle invasion is very high.”

05.08.2007

More on the subject:

Related articles

Photo

Article • Support for clinicians beyond initial diagnosis

Enhancing breast imaging with AI

Artificial intelligence has a critical role to play in supporting clinicians beyond the initial breast cancer diagnosis. At the European Society of Breast Imaging (EUSOBI) annual scientific meeting…

Photo

News • Imaging solutions

Fujifilm to unveil new ultrasound platforms at ECR 2026

Fujifilm Healthcare Europe will present the new Arietta DeepInsight x ultrasound technology platforms at the House of Fujifilm experience at ECR 2026: Rays of Knowledge.

Photo

News • Ultrasound, MRI and Enterprise Imaging

Esaote presents new imaging solutions at ECR 2026

Italian imaging company Esaote will be at the European Congress of Radiology 2026 (Booth 505, Expo Hall X5) and present latest additions to their ultrasound, MRI and Enterprise Imaging portfolio.

Subscribe to Newsletter